These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2128105)

  • 1. [Evaluation of prekallikrein activator (PKA) activity in plasma-derived preparations].
    Miks B; Aleksandrowicz J; Kawiak J
    Med Dosw Mikrobiol; 1990; 42(3-4):171-7. PubMed ID: 2128105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma kallikrein and prekallikrein activator (PKA) activities in various preparations of human immunoglobulins and albumins].
    Kawiak J; Aleksandrowicz J; Kawalec M; Drozdz M
    Med Dosw Mikrobiol; 1987; 39(3):203-7. PubMed ID: 3499549
    [No Abstract]   [Full Text] [Related]  

  • 3. A proposal for the Polish norm of PKA and KK content in plasma-derived preparations.
    Aleksandrowicz J; Fiejka M
    Rocz Panstw Zakl Hig; 1992; 43(3-4):311-5. PubMed ID: 1308750
    [No Abstract]   [Full Text] [Related]  

  • 4. The assay of prekallikrein activator in human blood products.
    Snape TJ; Griffith D; Vallet L; Wesley ED
    Dev Biol Stand; 1979; 44():115-20. PubMed ID: 317467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure alteration of IgG increased anticomplementary activity of intravenous immunoglobulin.
    Zang XX; Sun Y; Shen F; Wang D; Zhou L; Wang J; Kung E
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):415-9. PubMed ID: 8701757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an updated assay for prekallikrein activator in albumin and immunoglobulin therapeutics.
    Roberts G; Fox B; Longstaff C
    Vox Sang; 2021 Jan; 116(1):99-105. PubMed ID: 32986885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prekallikrein activator levels and side effects with human albumin preparations.
    Lüben G; Quast U; Geiger H
    Dev Biol Stand; 1980; 48():123-7. PubMed ID: 6974110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international collaborative study to replace the 1st international standard for prekallikrein activator.
    Longstaff C; Behr-Gross ME; Daas A; Lackner F
    Vox Sang; 2005 Feb; 88(2):143-51. PubMed ID: 15720613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A collaborative study to establish the 1st national standard of prekallikrein activator in Korea.
    Shin IS; Hong CM; Ban SJ; Hong SH
    Biologicals; 2012 Jan; 40(1):79-83. PubMed ID: 22122985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content.
    Römer J; Morgenthaler JJ; Scherz R; Skvaril F
    Vox Sang; 1982 Feb; 42(2):62-73. PubMed ID: 6977944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and elimination of hepatitis B immunoglobulins after intramuscular application in man.
    Scheiermann N; Kuwert EK
    Dev Biol Stand; 1983; 54():347-55. PubMed ID: 6653890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved, reliable and practical kinetic assay for the detection of prekallikrein activator in blood products.
    Shin IS; Shim YB; Hong CM; Koh HC; Lee SH; Hong SH
    Arch Pharm Res; 2002 Aug; 25(4):505-10. PubMed ID: 12214864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human plasma-derived immunoglobulin G fractionated by an aqueous two-phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectable in vitro thrombogenic activity.
    Vargas M; Segura Á; Wu YW; Herrera M; Chou ML; Villalta M; León G; Burnouf T
    Vox Sang; 2015 Feb; 108(2):169-77. PubMed ID: 25469648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F; Aznar J; Estelles A
    J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of European anti-D immunoglobulin preparations.
    Suomela H
    Vox Sang; 1991; 60(2):69-74. PubMed ID: 1827695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the Fc function in human immunoglobulins for intravenous administration. Multicenter study of the section 'Blood plasma Constituents' of the German Association for Transfusion Medicine and Immunohematology (DGTI).
    Kotitschke R
    Infusionsther Transfusionsmed; 1993 Jun; 20(3):93-5. PubMed ID: 8364334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.